- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 3 residues within 4Å:- Chain A: T.73
- Chain B: D.288, R.293
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Water bridges: B:D.288, B:D.288, B:R.293, B:R.293, B:R.293, B:R.293, A:T.73
- Salt bridges: B:R.293
- Hydrogen bonds: A:T.73, A:T.73
SO4.9: 1 residues within 4Å:- Chain B: R.117
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.117
SO4.14: 3 residues within 4Å:- Chain C: T.73
- Chain D: D.288, R.293
9 PLIP interactions:5 interactions with chain D, 4 interactions with chain C- Water bridges: D:D.288, D:D.288, D:R.293, D:R.293, C:T.73, C:T.73, C:D.74
- Salt bridges: D:R.293
- Hydrogen bonds: C:T.73
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
HEM.5: 22 residues within 4Å:- Chain A: M.87, G.90, Q.91, D.94, D.98, F.99, T.100
- Chain B: R.127, E.130, M.131, Y.184, T.217, F.220, R.221, G.223, H.224, I.227, F.253, F.295, L.305, L.308, R.312
24 PLIP interactions:18 interactions with chain B, 5 interactions with chain A, 1 Ligand-Water interactions,- Hydrophobic interactions: B:E.130, B:M.131, B:F.220, B:R.221, B:I.227, B:F.253, B:F.295, B:L.305, B:L.305, A:Q.91, A:Q.91
- Water bridges: B:R.127, B:R.221, B:R.221, B:R.221, B:R.221
- Salt bridges: B:R.127, B:R.221, B:R.312
- Metal complexes: B:H.224, H2O.3
- Hydrogen bonds: A:D.98, A:T.100, A:T.100
HEM.15: 23 residues within 4Å:- Chain C: M.87, G.90, Q.91, D.94, D.98, F.99, T.100
- Chain D: R.127, E.130, M.131, Y.184, T.217, F.220, R.221, Y.222, G.223, H.224, I.227, F.253, F.295, L.305, L.308, R.312
22 PLIP interactions:4 interactions with chain C, 18 interactions with chain D,- Hydrophobic interactions: C:Q.91, C:Q.91, D:E.130, D:M.131, D:F.220, D:R.221, D:Y.222, D:I.227, D:F.253, D:F.295, D:L.305, D:L.305
- Hydrogen bonds: C:D.98, C:T.100
- Water bridges: D:R.221, D:R.221, D:R.221, D:R.221
- Salt bridges: D:R.127, D:R.221, D:R.312
- Metal complexes: D:H.224
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 6 residues within 4Å:- Chain B: N.77, N.80, L.84, A.86, V.87, Q.89
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:A.86
- Hydrogen bonds: B:N.80, B:V.87, B:Q.89, B:Q.89
- Water bridges: B:N.77, B:N.77, B:N.77
NAG.7: 5 residues within 4Å:- Chain B: N.113, S.115, A.116, W.257, L.261
No protein-ligand interaction detected (PLIP)NAG.16: 6 residues within 4Å:- Chain D: N.77, N.80, L.84, A.86, V.87, Q.89
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:N.80, D:V.87, D:Q.89, D:Q.89
- Water bridges: D:N.77
NAG.17: 4 residues within 4Å:- Chain D: N.113, S.115, A.116, W.257
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.113
- 2 x CA: CALCIUM ION(Non-covalent)
CA.8: 5 residues within 4Å:- Chain A: D.96
- Chain B: T.56, F.58, D.60, S.62
5 PLIP interactions:1 interactions with chain A, 4 interactions with chain B- Metal complexes: A:D.96, B:T.56, B:F.58, B:D.60, B:S.62
CA.18: 5 residues within 4Å:- Chain C: D.96
- Chain D: T.56, F.58, D.60, S.62
5 PLIP interactions:4 interactions with chain D, 1 interactions with chain C- Metal complexes: D:T.56, D:F.58, D:D.60, D:S.62, C:D.96
- 6 x ACT: ACETATE ION(Non-functional Binders)
ACT.10: 4 residues within 4Å:- Chain B: P.11, P.12, R.36, R.49
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:P.11
- Water bridges: B:R.49
- Salt bridges: B:R.49
ACT.11: 2 residues within 4Å:- Chain B: M.410, R.413
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:M.410
- Salt bridges: B:R.413
ACT.12: 3 residues within 4Å:- Chain B: P.191, R.195, R.375
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:P.191
- Salt bridges: B:R.195, B:R.375
ACT.19: 3 residues within 4Å:- Chain D: P.12, R.36, R.49
2 PLIP interactions:2 interactions with chain D- Salt bridges: D:R.36, D:R.49
ACT.20: 2 residues within 4Å:- Chain D: M.410, R.413
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:R.413
ACT.21: 3 residues within 4Å:- Chain D: P.191, R.195, K.376
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:P.191
- Salt bridges: D:R.195, D:R.375, D:K.376
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fiedler, T.J. et al., X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J.Biol.Chem. (2000)
- Release Date
- 2000-04-24
- Peptides
- MYELOPEROXIDASE: AC
MYELOPEROXIDASE: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x CA: CALCIUM ION(Non-covalent)
- 6 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fiedler, T.J. et al., X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J.Biol.Chem. (2000)
- Release Date
- 2000-04-24
- Peptides
- MYELOPEROXIDASE: AC
MYELOPEROXIDASE: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D